Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Pituitary Neoplasms 2Pituitary Diseases 1Pheochromocytoma 1Non-functioning Pituitary Adenoma 1Insulinoma 1Hyperinsulinism 1Congenital Hyperinsulinism 1Adrenal Insufficiency 1

Interventions

pasireotide 7Cabergoline 7Surgical Procedures, Operative 4Temozolomide 3Propofol 3Hydrocortisone 3Dexmedetomidine 3lanreotide 2Sevoflurane 2Saline Solution 2Rosiglitazone 2Radiotherapy 2Radiosurgery 2Proton Therapy 2Octreotide 2Human Growth Hormone 2Dexamethasone 2Desflurane 2Aminolevulinic Acid 2pegvisomant 1parecoxib 1lutetium Lu 177 dotatate 1loxoprofen 1farletuzumab 1entinostat 1corticorelin ovine 1antineoplaston AS 2-1 1antineoplaston A10 1Yoga 1Visual Field Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Saline Solution × Endocrine × Clear all
NCT04621565 2020-11-09

Hydrocortisone Use During Peri-operation for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
436 enrolled
Endocrine

Adrenal Insufficiency, Pituitary Neoplasms

NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pontificia Universidad Catolica de Chile

Phase 4 Unknown
40 enrolled
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡